Prof. Dr. Murat Tuncel

Ankara Atatürk Anadolu Lisesi’nden 1993 yılı sonunda mezun olduktan sonra, Hacettepe Üniversitesi Tıp Fakültesinde eğitimime devam ettim. Tıp doktoru olduktan sonra 2000 yılında Hacettepe Üniversitesi Nükleer Tıp Anabilim Dalında uzmanlık eğitimine başladım. Uzmanlık sonrası 2005 yılında kendimi geliştirmek üzere Deutscher Akademischer Austauschdienst (DAAD) bursu kazanarak Münih Teknik Üniversitesi’nde çalışmalarıma devam ettim. Yaklaşık 1 yıl süren eğitim sonrası Türkiye dönüşünde askerliğimi Gülhane Askeri Tıp Akademisi (GATA) hastanesinde yaptım. Askerlik sonrası akademik hayatıma Hacettepe Nükleer Tıp bölümünde devam ettim. Bu bölümde 2019 yılından beri Profesör Dr. Öğretim görevlisi olarak çalışmaya devam etmekteyim. Avrupa Nükleer Tıp derneği, Tiroid komitesinde üyeliğim bulunmakta olup pek çok uluslararası çalışma ve eğitim verme tecrübem oldu. Türkiye Nükleer Tıp Derneği, Teranostik Onkoloji Derneği gibi pek çok mesleki üyeliklerim bulunmaktadır. İngilizce ve Almanca bilmekteyim.
Özel ilgi alanlarım iyi veya kötü huylu tiroid ve paratiroid hastalıklarının tanı, tedavi ve görüntülenmesi, ultrasonografi, prostat ve nöroendokrin tümörlerde radyonüklid tedavilerdir.
81’i uluslararası hakemli dergilerde yayınlanmış toplam 105 araştırma makalesi, 80’i uluslararası olmak üzere 120 kongre bildirim bulunmaktadır. Çok sayıda ulusal ve uluslararası kongrede organizasyon komitesi, bilimsel kurul üyeliği ve konuşmacı olarak görev aldım.

• Tıp Fakültesi: Hacettepe Üniversitesi Tıp Fakültesi (1994-2000) Ankara, Türkiye
• Uzmanlık Alanı: Hacettepe Üniversitesi Tıp Fakültesi Nükleer Tıp Anabilim Dalı (2000-2005)
• Doktora sonrası burs: PET ve PET/CT doktora sonrası 'burs' programı (Ekim 2005-Temmuz 2006) Klinik und Poliklinik für Nuklearmedizin Klinikum Rechts der Isar Technische Universitat Münih, Münih, Almanya.
• Askerlik Hizmeti: Gülhane Askeri Tıp Akademisi ve Tıp Fakültesi Nükleer Tıp Anabilim Dalı, Etlik-Ankara (Şubat 2008-Şubat 2009)

• İngilizce
• Almanca

• Gursan Kaya, Serkan Akin, Murat Tuncel, Pinar Kiratli. Plasmacytoma and Amyloid Lymphadenopathy, FDG, and Fluorocholine. Clin Nucl Med . 2024 Apr 1. doi: 10.1097/RLU.0000000000005210.
• Luca Giovanella, Murat Tuncel, Atena Aghaee, Alfredo Campenni, Petra Petranović Ovčariček, Armando De Virgilio. Theranostics of Thyroid Cancer Semin Nucl Med 2024 Mar 18: 00011-4. doi: 10.1053/j.semnuclmed .
• Kreissl MC, Ovčariček PP, Campenni A, Vrachimis A, Tuncel M, Giovanella L. The European Association of Nuclear Medicine (EANM)'s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight? Eur J Nucl Med Mol Imaging. 2024 Jan 16. doi: 10.1007/s00259-023-06571-z.
• Luca Giovanella, Alfredo Campennì, Murat Tuncel, Petra Petranović Ovčariček. Integrated Diagnostics of Thyroid Nodules. Cancers (Basel). 2024 Jan 11;16(2):311. doi: 10.3390/cancers16020311.
• Basak Soydas-Turan, Murat Tuncel. Unexpected Axillary Lymph Node Uptake During Lower-Limb Lymphoscintigraphy in a Case With Vulvar Lymphangioma Circumscriptum. August 2023 Clinical Nuclear Medicine 48(10):879-880
• Petra Petranović OvčaričekAlfredo Campennì Alfredo CampennìBart de KeizerBart de Keizer Desiree Deandreis, Michael C. Kreissl, Alexis Vrachimis, Murat Tuncel and Luca Giovanella. Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer. August 2023 Cancers 15(17)
• Rie von Eyben; Manuela Andrea Hoffmann; Cigdem Soydal; Irene Virgolini; Tuncel M; Mathieu Gauthé; Daniel S. Kapp; Finn Edler von Eyben. Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer. Biomedicine 2023-08-22 DOI: 10.3390/biomedicines11092333
• Kupik O, Tuncel M, Özgen Kıratlı P, Akpınar MG, Altundağ K, Başaran Demirkazık F, Erbaş B Value of Dynamic 18F-FDG PET/CT in Predicting the Success of Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: A Prospective Study. Mol Imaging Radionucl Ther. 2023 Jun 20;32(2):94-102.
• Mehmet Karabuga, Suna Erdogan, Kürsat Filikci, Rıfkı Hazıroglu, Murat Tuncel, Mustafa Cengiz. Evaluation of efficacy of tumor-specific nanoliposomal radiosensitizer in radiotherapy. Journal of Drug Delivery Science and Technology, 2023, 104586, https://doi.org/10.1016/j.jddst.2023.104586.
• Luca Giovanella, Lisa Milan, Wolfgang Roll, Manuel Weber, Simone Schenke, · Michael Kreissl, Alexis Vrachimis, Kim Pabst, Tuncel Murat, Petra Petranovic Ovcaricek, Burkhard Riemann, Luca Ceriani, Alfredo Campenni, Rainer Görges et al. Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2023). https://doi.org/10.1007/s00259-023-06239-8
• Tugce Telli, Murat Tuncel , Erdem Karabulut , Sercan Aksoy , Mustafa Erman ,Bulent Akdogan ,Meltem Caglar. Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617. A single-center prospective observational study. The Prostate. 2023;1–9.
• Banu Erturk, Murat Tuncel, Diclehan Orhan, Ozlem Bozbeyi Turer, Omer Dizdar ,and Suleyman Nahit Sendur. SHDB mutant functional metastatic paraganglioma:The efficacy of Lutetium-177 DOTATE JCEM Case Reports, Volume 1, Issue Supplement_1, January 2023, luac014.003,
• Osman Kupik, Bayram Şen, Medeni Arpa, Uğur Avcı, Hasan Gündoğdu, Süleyman Kalcan, Hasan Güçer, Şafak Akın, Murat Tuncel. The effect of thyroid hormone withdrawal performed to evaluate the success of I-131 ablation on quality of life and psychological symptoms in female patients with low-risk differentiated thyroid cancer. J Health Sci Med 2023; 6(1): 66-72DOI: 10.32322/jhsm.1196968Received: 01.11.2022
• Rie von Eyben, Daniel S. Kapp, Manuela Andrea Hoffmann, Cigdem Soydal, Christian Uprimny,Irene Virgolini, Murat Tuncel, Mathieu Gauthé andFinn E. von Eyben.,* A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis by Cancers 2022, 14(21), 5461; https://doi.org/10.3390/cancers14215461
• Kaya G, Tuncel M. FDG-PET/CT Imaging of Large Vessel Vasculitis January 2022 Acta Medica
• Osman Kupik, Murat Tuncel, Pınar Özgen Kıratlı, Meltem Gülsün Akpınar, Kadri Altundağ, Figen Başaran Demirkazık, Belkıs Erbaş.18F FDG PET/CT after Neoadjuvant Chemotherapy and Pathological Responses are Predictive Factors for Disease-Free Survival and Overall Survival in Patients with Locally Advanced Breast Cancer: A Prospective Study 2 UHOD Number: 3 Volume: 32 150-158 Year: 2022
• Osman Kupik, Murat Tuncel, Pınar Özgen Kıratlı, Meltem Gülsün Akpınar, Kadri Altundağ, Figen Başaran Demirkazık, Belkıs Erbaş. Predictive Value of Dual-phase 18F-FDG PET/CT in theAssessment of Neoadjuvant Chemotherapy Responsein Patients with Locally Advanced Breast Cancer:A prospective Comparative Study with DynamicContrast-enhanced Magnetic Resonance ImagingReceived: Turk J Oncol 2022;37(4):426–35
• Petra Petranović Ovčariček, Michael C Kreissl, Alfredo Campenni, Bart de Keizer, Murat Tuncel, Alexis Vrachimis, Desiree Deandreis, Luca Giovanella. SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management-the EANM perspective. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):3959-3963. doi: 10.1007/s00259-022-05935-1.
• Doruk Arslan, Fadime Sinem Ardıc, Ozge Berna Gultekin-Zaim, Murat Tuncel, Neyran Kertmen, Rahsan Gocmen, Fatma Gokcem Yildiz, Ersin Tan. Cerebellar hypermetabolism: an alternative marker for diagnosis of paraneoplastic cerebellar degeneration Neurologia (Engl Ed). 2022 Aug 29;S2173-5808(22)00091-8. doi: 10.1016/j.nrleng.2022.08.003. Online ahead of print.
• Schenke SA, Campennì A, Tuncel M, Bottoni G, Sager S, Crncic TB, Rozic D, Görges R, Özcan PP, Groener D, Hautzel H, Klett R, Kreissl MC and Giovanella L. Diagnostic Performance of 99m Tc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study. Diagnostics 2022, 12, 1358. https://doi.org/10.3390/diagnostics12061358
• Tuncel M, Vrachimis A, Campenni A, de Keizer B, Verburg FA, Kreissl MC, Ovcaricek PP, Geliashvili T, Giovanella L. To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment Eur J Nucl Med Mol Imaging 2022 May 18. doi: 10.1007/s00259-022-05841-6.
• Süslü NS, Katar O,Tuncel M. Role of indocyanine green combined with radiotracer-Technetium 99 m in neck surgery for primary and recurrent head and neck cancer: preliminary results of a tertiary cancer center. Eur Arch Otorhinolaryngol 2022 Mar;279(3):1549-1560
• von Eyben R, Hoffmann MA, Kapp DS, Soydal C, Uprimny C, Virgolini I, Tuncel M, Gauthé M, von Eyben FE. Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse Eur Urol Oncol 2022 Feb 5; 00006-2. doi: 10.1016/j.euo .
• Schenke SA, Campenni A, Tuncel M, Piccardo A,, Sager S,·Crncic TB, Rozic D · Goerges R, Kara PPO, Groener D, Hautzel H, Klett R, · Michael Christoph Kreissl MC, Giovanella L. A multicenter survey of current practices of 99mTc-methoxy-isobutyl-isonitrile (MIBI) imaging for the diagnosis of thyroid nodules: more standardization is essential. June 2021 Clinical and Translational Imaging. doi.org/10.1007/s40336-021-00439-8
• Kaya G, Turan BS, Dagdelen S, Berker M, Tuncel M. 68Ga-DOTATATE PET/CT in Pituitary Carcinoma. Clin Nucl Med 2021 Dec 1;46(12):996-998.
• 5Mavi ME, Tuncel M. Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy. Clin Nucl Med 2021 May 26. doi: 10.1097/RLU.0000000000003731.
• Onal C, Ozyigit G, Oymak E,Guler OC, Pervin Hurmuz, Tilki B, Reyhan M, Tuncel M, Akyol F. Clinical parameters and nomograms for predicting lymph node metastasis detected with 68 Ga-PSMA-PET/CT in prostate cancer patients candidate to definitive radiotherapy) Prostate 2021 May 5. doi: 10.1002/pros.24142.
• Doğan R, Uysal S, Kumbasar U, Köksal D, Ancın B, Tuncel M. Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection? Tuberk Toraks 2021 Mar;69(1):59-64.
• Ann Nucl Med 2021 May;35(5):529-539. doi: 10.1007/s12149-021-01593-9
• Tuncel M,Telli T,Tuncalı MÇ, Karabulut E. Predictive factors of tumor sink effect: insights from 177Lu-Prostate-specific membrane antigen therapy
• Telli T, Kaya G, Işık Z, Tuncel M. Colonic Visualization of 99mTC-DMSA Due to Enterovesical Fistula. Clin Nucl Med. 2021 Jan;46(1):66-68
• Karpuz M, Gunay MS, Ozer Y, Ozturk SC, Yanık H, Tuncel M, Aydın C,Esendaglı G. Diagnostic And Therapeutic Evaluation Of Folate-Targeted Paclitaxel And Vinorelbine Encapsulated Theranostic Liposomes For Non-Small Cell Lung Cancer. European Journal of Pharmaceutical Sciences 2021 Jan 1;156:105576.doi: 10.1016/j.ejps.2020.105576.
• Caglar M, Tuncel M, Yildiz E, Karabulut E. Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT. Ann Nucl Med 2020 Dec;34(12):932-941. doi: 10.1007/s12149-020-01529-9..
• Onal C, Ozyigit G, Guler OC, Hurmuz P, Torun N, Tuncel M, Dolek Y, Yedekci Y, Oymak E, Tilki B, Akyol F. Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients Radiotherapy and Oncology. 2020 Oct;151:222-227. doi: 10.1016/j.radonc.2020.08.021.
• Asi T, Tuncalı MÇ, Tuncel M, Alkanat EİA, Hazır B, Kösemehmetoğlu K, Baydar DE, Akdoğan B. The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit? Urologic Oncology: Seminars and Original Investigations August 2020 2020 Dec;38(12):937.e11-937.e17.
• Tuncel M, Tuncalı MÇ, Telli T, Erman M .Clinical Impact of PET Imaging in Patients With Metastatic Prostate Cancer. Clin Nucl Med. 2020 Oct;45(10):757-764.
• Tuncel M, Kılıçkap S, Süslü N. Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer. Ann Nucl Med. 2020 Jun 34(9):663-674. doi: 10.1007/s12149-020-01494-3.
• Gultekin M, Esen CSB, Akgor U, Salman MC,Tuncel M, Ozmen M, Yildiz F. Using a pessary during radiotherapy in reducible pelvic organ prolapse and vaginal cancer: a case report and review of the literature.
• Yilmaz MT, Gultekin M, Yalcin S, Tuncel M, Gedikoglu G, Yildiz F, Cengiz M Stereotactic ablative radiotherapy for bone metastasis of gastrointestinal stromal tumor: Case report and review of the literature. Rep Pract Oncol Radiother. 2020 May-Jun;25(3):331-335. doi: 10.1016/j.rpor.2020.02.013.
• Kupik O, Akin S,Tuncel M, Eren G, Türker A, Kars A, Erbaş B.Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement. Nucl Med Commun. 2020 Jun;41(6):540-549
• Aydın K, Ersöz Gülçelik N, Tuncel M, Balcı C, Akın Ş, Çınar N, Fırat F,Çağlar M, Usman A, Gürlek A. Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment. Turk J Med Sci. 2019 Jun 18;49(3):738-745. doi: 10.3906/sag-1708-106.
• Gunay MS, Karpuz M, Ozturk N, Ozer AY, Erdogan S, Tuncel M. Radiolabeled, folate-conjugated liposomes as tumor imaging agents: Formulation and in vitro evaluation. Journal of Drug Delivery Science and Technology Volume 50, April 2019, Pages 321-328
• Tuncel M, Süslü N Radioguided occult lesion localization in patients with recurrent thyroid cancer. Eur Arch Otorhinolaryngol. Eur Arch Otorhinolaryngol. 2019 Jun;276(6):1757-1766. doi: 019-05377-w. Epub 2019 Mar 18.2019 Mar 18. doi: 019-05377-w.
• Telli T, Tuncel M, Kılıckap S. Critical Role of Ga–68 DOTATATE PET-CT in a Patient with Neuroendocrine Tumor and Second Primary Cancer. - Turk J Endocrinol Metab 2019;23:58-63. Doi: 10.25179/tjem.2018-62733
• Akdemir EN, Tuncel M, Akyol F, Bilen CY, Baydar DE, Karabulut E, Ozen H, Caglar M. 68Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer. World J Urol. 2019 May;37(5):813-821. doi: 10.1007/s00345-018-2460-y
• Sentinel Lymph Node Biopsy: Actual Approaches. Tuncel M, Salancı BV, Murat Fani Bozkurt MF. Nuclear Medicine Seminars / Nükleer Tıp Seminerleri 2017;3:78-88
• Tuncel M, Telli T. Value of post-therapy 177Lu PSMA images for accurate interpretation of therapy response with 68Ga-PSMA PET/CT. Rev Esp Med Nucl Imagen Mol. 2017 Jul 24. pii: S2253-654X(17)30092-6.
• Tuncel M. Thyroid Stimulating Hormone Receptor. Mol Imaging Radionucl Ther. 2017 Feb 9;26(Suppl 1):87-91. doi: 10.4274/2017.26.suppl.10.
• Kanat NB, Tuncel M, Aksoy T, Fırat A,Demirkazık, F, Onat D, Tuncalı MÇ, Caner BE. Comparison of Wire-Guided Localization and Radioguided Occult Lesion Localization in Preoperative Localization of Non-Palpable Breast Lesions. Turk J Med Sci 2016 Dec 20;46(6):1829-1837
• Tuncel M, Lay Ergun E, Caglar Tuncali M. Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach. J BUON. 2016 Sept-Oct;21(5):1296-1306.
• Erbas B, Tuncel M. Renal Function Assessment During Peptide Receptor Radionuclide Therapy. Semin Nucl Med. 2016 Sep;46(5):462-78
• Okuyucu K, Ozaydın S, Alagoz E, Ozgur G, Ince S, Oysul FG4, Ozmen O, Tuncel M, Ozturk M, Arslan N. Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma. Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma. Radiol. and Oncol. 2016 Sep 8;50(4):360-369
• Akın Ş, Akın S, Tuncel M, Gülçelik NE. Symptomatic Adrenal Insufficiency due to Bilateral Adrenal Non-Hodgkin’s Lymphoma Turk J Endocrinol Metab 2016;20:108-110
• Kiratli PÖ, Tuncel M, Bar-Sever Z. Nuclear Medicine in Pediatric and Adolescent Tumors. Semin Nucl Med. 2016 Jul;46(4):308-23.
• Soyer T, Karnak İ, Tuncel M, Ekinci S, Andıran F, Çiftçi AÖ, Akçören Z, Orhan D, Alikaşifoğlu A, Özön A, Tanyel FC. Results of intraoperative gamma probe survey and frozen section in surgical treatment of parathyroid adenoma in children. J Pediatr Surg. 2016 Sep;51(9):1492-5
• Silindir M, Erdoğan S, Ozer AY, Doğan AL, Tuncel M, Uğur O, Torchilin VP. Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT. J Liposome Res. 2013 Mar;23(1):20-7
• Ozdemir D, Dagdelen S, Kiratli P, Tuncel M, Erbas B, Erbas T. Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster. Minerva Endocrinol. 2012 Sep;37(3):267-7
• Tuncel M, Akdemir E. (99m)Tc-MDP uptake in thyroid nodule: Contribution of SPECT-CT and ultrasonography. Rev Esp Med Nucl Imagen Mol. 2012 Jan-Feb;31(1):49-50
• Tuncel M, Kiratli PO, Gedikoglu G. SPECT-CT imaging of poliostotic fibrous dysplasia. Rev Esp Med Nucl Imagen Mol. 2012 Jan-Feb;31(1):47-8
• Tuncel M, Caner B. Osteopoikilosis: a major diagnostic problem solved by bone scintigraphy. Rev Esp Med Nucl Imagen Mol. 2012 Mar-Apr;31(2):93-6
• Tuncel M, Kıratlı PO, Aksoy T, Bozkurt MF. Gastroesophageal reflux scintigraphy: interpretation methods and inter-reader agreement. World J Pediatr. Aug;7(3):245-9. (2011)
• Arslan N, Tuncel M, Kuzhan O, Alagoz E, Budakoglu B, Ozet A, Ozguven MA. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D: -glucose with positron emission tomography in patients with small cell lung cancer. Ann Nucl Med. Jul;25(6): )
• Tuncel M, Topbasi Z, Kiratli PO. Butterfly vertebra: a diagnostic pitfall on bone scintigraphy.Clin Nucl Med. 2010 Apr;35(4):293-4.
• Ergun EL, Tuncel M, Bozkurt MF, Caner B. Simultaneous Anterior-posterior Dynamic Renal Scintigraphy For The Evaluation Of Congenital Abnormal Kidneys
• Kiratli PO, Tuncel M, Ozkutlu S, Caglar M. Gated myocardial perfusion scintigraphy in children with myocarditis: can it be considered as an indicator of clinical outcome?Nucl Med Commun. 2008 Oct;29(10):907-14.
• Tuncel M, Souvatzoglou M, Herrmann K, Stollfuss J, Schuster T, Weirich G, Wester HJ, Schwaiger M, Krause BJ [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer. Nucl Med Biol. 2008 Aug;35(6):689-95.
• Krause BJ, Souvatzoglou M, Tuncel M, Herrmann K, Buck AK, Praus C, Schuster T, Geinitz H, Treiber U, Schwaiger M. The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):18-23.
• Tuncel M. Correspondence: diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions. Nucl Med Commun. 2007 Nov;28(11):879-80
• Tuncel M, Kiratli Ozgen P. Vascular retention of 99mTc-pertechnetate and 99mTc-sestamibi, mimicking thyroid carcinoma metastases. Revista Medicina Nuclear 26 (4): 226-92007
• Tuncel M, Aydin D, Çankaya EY, Tazebay UH, Guc D, Dogan AL, Tasbasan B, Uğur O. The comparative effects of gene modulators on thyroid specific genes and radioiodine uptake. Cancer Biotherapy & Radiopharmaceuticals. 22 (3):443-449, 2007.
• Tuncel M, Kiratli PO, Mahmoudian B. Behcet disease with an intrapulmonary shunt. Clin Nucl Med 31: 181-182, 2006.
• Tuncel M, Ergun EL. Value of Hepatobiliary scintigraphy after type 1 choledochal cyst excision and Roux-en-Y Hepatojejunostomy. Clin Nucl Med 31:93-95, 2006.
• Turker S, Erdogan S, Ozer AY, Ergun EL, Tuncel M, Bilgili H, Deveci S. Scintigraphic imaging of radiolabelled drug delivery systems in rabbits with arthritis. Int J Pharm 30; 296:34-43, 2005.
• Mahmoudian B, Kiratli PO, Tuncel M, Bozkurt MF. Selected intra-arterial injection of Tc-99m MDP. Rev Esp Med Nucl 23(4):284-5, 2004.
• Caglar M, Tuncel M, Alpar R. Value of technetium scintigraphy and iodine uptake measurement during follow-up of differentiated thyroid cancer. Ann Nucl Med 18: 479-482, 2004.
• Caglar M ,Tuncel M, Usubutun A. Increased uptake on I-131 Whole-body scintigraphy in Warthin tumor despite false-negative Tc-99m pertechnetate salivary gland scintigraphy. Clin Nucl Med 28: 945-946, 2003.
• Tuncel M, Mahmoudian B, Erbas B. 99mTc-MDP Uptake in Cutaneous Calcinosis due to Calcium-gluconate Infiltration. Semin Nucl Med 4: 334-337, 2003.
• Caglar M, Tuncel M , Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med 27: 767-71, 2002.
• Caglar M, Tuncel M. Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation. Clin Nucl Med 27: 532-3, 2002.
• Tuncel M, Caglar M. Osteoid osteoma of the rib detected on bone scintigraphy: importance of pattern recognition. Clin Nucl Med 27: 216-7, 2002

• Tiroid Hastalıkları
• Tiroid Kanseri
• Hipertiroidi
• Tiroid Nodülü
• Hipertiroidizm (Zehirli Guatr)
• Guatr (yumrulu)
• Prostat Kanseri
• Nöroendokrin tümör
• PSMA
• Lu-177
• Radyoaktif iyot
• I-131
• Lutesyum tedavisi
• Nöroendokrin tümör tedavisi
• NET
• Lutesyum
• PET
• Galyum PET
• PSMA PET
• Atom tedavisi